Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Tumor-Agnostic 1Plasma cell 1Other neoplasm 1Myeloid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Liver Neoplasms 1

Interventions

Colonoscopy 67Blood Specimen Collection 64Standard of Care 60Exercise 59Radiosurgery 53Drug Therapy 49Radiofrequency Ablation 47Endoscopic Mucosal Resection 47Radiotherapy 45Surgical Procedures, Operative 44Methods 43Early Intervention, Educational 40Surveys and Questionnaires 39Oxaliplatin 38Laparoscopy 34Educational Status 34Fluorouracil 33Magnetic Resonance Spectroscopy 28Gemcitabine 26Biopsy 26Preoperative Exercise 25Practice Guidelines as Topic 24Control Groups 24lenvatinib 23Patient Navigation 23Electroporation 23Capecitabine 22camrelizumab 20Saline Solution 20Liver Transplantation 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Oxycodone × Gastrointestinal × Clear all
NCT06003218 2025-04-02

Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation

Peking University First Hospital

Phase NA Completed
88 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡